Annals of Clinical and Laboratory Research

  • ISSN: 2386-5180
  • Journal h-index: 16
  • Journal CiteScore: 5.60
  • Journal Impact Factor: 4.86
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
+44 7460731551
Awards Nomination
Indexed In
  • Genamics JournalSeek
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • Directory of Research Journal Indexing (DRJI)
  • Publons
  • Euro Pub
  • Google Scholar
  • Secret Search Engine Labs
Share This Page


A revolutionary approach to drug development and treatment based on pharmacogenomics

Hillin Jiayuan*

Pharmacogenomics, the study of how an individual's genetic makeup influences drug response, has revolutionized drug development and treatment approaches. This article explores the profound impact of pharmacogenomics on personalized medicine, highlighting its role in optimizing drug efficacy, minimizing adverse reactions, and guiding treatment decisions based on an individual's genetic profile. By understanding the genetic variations that affect drug metabolism, transport, and targets, researchers and clinicians can tailor drug therapies, improve patient outcomes, and pave the way for precision medicine.